John Couling Sells 6,164 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 6,164 shares of the business’s stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $66.12, for a total value of $407,563.68. Following the completion of the sale, the senior vice president owned 115,338 shares of the company’s stock, valued at $7,626,148.56. The trade was a 5.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Dolby Laboratories Stock Performance

Shares of DLB stock traded down $0.79 during mid-day trading on Monday, hitting $66.69. The company’s stock had a trading volume of 889,246 shares, compared to its average volume of 465,609. Dolby Laboratories has a 52-week low of $64.02 and a 52-week high of $89.66. The stock has a market cap of $6.39 billion, a price-to-earnings ratio of 24.43 and a beta of 0.97. The business has a 50-day moving average price of $68.59 and a 200 day moving average price of $72.34.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. The firm had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company’s revenue was up .7% on a year-over-year basis. During the same period last year, the firm earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. Equities research analysts predict that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd will be given a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s payout ratio is currently 54.75%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on DLB shares. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday. Tigress Financial increased their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research report on Friday, August 15th. Barrington Research lowered their price objective on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Rosenblatt Securities decreased their target price on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Finally, Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.00.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. First Horizon Corp acquired a new stake in Dolby Laboratories during the 3rd quarter worth about $25,000. Hantz Financial Services Inc. boosted its stake in Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after buying an additional 220 shares in the last quarter. Cheviot Value Management LLC bought a new position in Dolby Laboratories in the 1st quarter valued at $27,000. MAI Capital Management boosted its position in Dolby Laboratories by 87.1% in the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock valued at $28,000 after buying an additional 162 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd bought a new stake in shares of Dolby Laboratories during the 1st quarter valued at $29,000. Institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.